Clinical Trials Browser

Phase 3 × Interferons × Other hematologic neoplasm × Clear all

NCT06802718 2025-01-31

Interferon-alpha As Maintenance Therapy for Favorable-risk Acute Myeloid Leukemia

Phase 3 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute